Catalyst Wire Dossier Catalyst Wire Dossier

Two FDA-approved antiretroviral drugs (combined tablet)

· ViiV Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Two FDA-approved antiretroviral drugs (combined tablet), covering 2020-03-24 to 2020-03-24. Get the full timeline:

Most recent: Clinical Trial Update: New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects [Phase 3]

See pricing